International Cannabis News

A recent BDSA report found that global cannabis sales reached nearly $21.3 billion last year.

Lawmakers in Morocco are set to legalize the production and use of medical cannabis products as soon as next week.

Former NBA player and coach Isiah Thomas has invested $3 million into One World Pharma, a licensed hemp and cannabis ingredient producer in Colombia.

The Chief Marketing Officer for British American Tobacco, the world’s second-largest tobacco company, said CBD is “an exciting growth area” for the company’s future.

Cann Group Limited in Australia said last week it lost $3.6 million when payments meant for an overseas contractor were, “received by an unknown third party as a result of a complex and sophisticated cyber fraud.”

GW Pharmaceuticals, creator of the first FDA-approved medication made from cannabis, is set to be purchased by Jazz Pharmaceuticals in a $7.2 billion cash-and-stock deal.

Cannabis industry analytics firm Headset released a new report estimating the annual value of Mexico’s legalized cannabis market at about $843.7 million.

New Zealand law enforcement officials have ended the country’s annual cannabis eradication operation, choosing instead to focus on combating “more harmful substances such as methamphetamine.”

The French government has launched a public consultation to ask citizens about their views on cannabis legalization and to determine which government policies the people would prefer.

20 years after issuing its first medical cannabis cultivation permit, the United Kingdom has awarded a second such license to Jersey-based Northern Leaf.

Mexico health officials have published rules for the country’s medical cannabis industry and President Andres Manuel López Obrador approved regulations letting pharmaceutical companies conduct medical cannabis research.

North Wales Police and Crime Commissioner Afron Jones has called for giving drug-dependent inmates cannabis to determine whether it might reduce overdose deaths and violence.

Amsterdam’s Mayor Femke Halsema has officially introduced her plan to ban cannabis sales to tourists and foreigners in the city.

Colombia’s Superintendency of Industry and Commerce has suggested the South American nation consider legalizing THC-rich exports for the global medical cannabis market.

The Australian biotech company Neurotech International Ltd. announced it has completed studies using human brain cells to investigate the anti-inflammatory and neuro-modulatory properties of two proprietary cannabis strains.

Starting next year — after the final transition period of Brexit — medical cannabis patients in the UK will no longer be able to source their medicine from The Netherlands or other EU countries.

Irish medical cannabis patients no longer have to travel to The Netherlands to purchase their medicine after officials made permanent a pandemic-response service that lets patients order medical cannabis products from Dutch cannabis firms.

The UK has approved trials to assess the safety — and eventually efficacy — of DMT as a potential treatment for depression.

Mexican lawmakers are requesting an extension to their December 15 deadline to pass a cannabis legalization law. The bill as it stands would allow for possession up to 28 grams, home cultivation, a legal market, and the expungement of some prior cannabis crimes.

A former civilian employee for the U.S. Marine Corps was sentenced to four years and four months in prison in Japan after he was arrested last year for illegal cannabis sales.

The Thai government has ruled that most parts of the cannabis/hemp plant — including the leaves, branches, trunks, bark, fiber, and roots (not flower) — are now allowed in manufactured cosmetics and food.

A bill to legalize adult-use cannabis passed through Mexico’s Senate yesterday and will move next to the lower house of Congress.

The European Union’s highest court has ruled that CBD is not a narcotic because it does not have any psychotropic or harmful effects.

Canadian cannabis activists and law enforcement agencies both say that product from personal medical cannabis grows is being diverted into the unregulated market.